Latest Breaking News On - Lipocine daily - Page 7 : comparemela.com

StockNews com Initiates Coverage on Lipocine (NASDAQ:LPCN)

StockNews.com began coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a report issued on Monday morning. The firm issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Trading Down 4.3 % Shares of NASDAQ LPCN opened at $3.82 on Monday. Lipocine has a twelve month low of $3.30 and a twelve […]

Lipocine company profileRenaissance technologiesGoldman sachs group incLipocine incMillennium managementBlackrock incFree reportTrading downGet free reportStreet corpGoldman sachs groupSachs groupLipocine dailyNasdaq lpcnInitiated coverageStocknews com

Lipocine (NASDAQ:LPCN) Coverage Initiated at StockNews com

Lipocine (NASDAQ:LPCN) Coverage Initiated at StockNews com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Blackrock incRenaissance technologiesLipocine company profileGoldman sachs group incMillennium managementLipocine incGet free reportStreet corpGoldman sachs groupSachs groupLipocine daily

Lipocine (NASDAQ:LPCN) Earns Buy Rating from Analysts at StockNews com

Lipocine (NASDAQ:LPCN) Earns Buy Rating from Analysts at StockNews com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Lipocine incRenaissance technologiesEp wealth advisorsBlackrock incTopco ltdFree reportTrading downGet free reportStreet corpLipocine daily

Lipocine (NASDAQ:LPCN) Now Covered by StockNews com

StockNews.com initiated coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research note published on Saturday. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Price Performance Lipocine stock opened at $4.16 on Friday. The stock has a market cap of $22.11 million, a price-to-earnings ratio of -1.75 and […]

Maheshv patelMillennium managementSecurities exchange commissionGoldman sachs group incBlackrock incLipocine incRenaissance technologiesFree reportExchange commissionStreet corpGoldman sachs groupSachs groupGet free reportLipocine dailyNasdaq lpcnInitiated coverage

Lipocine (NASDAQ:LPCN) Coverage Initiated by Analysts at StockNews com

StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research note issued to investors on Friday morning. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Stock Up 1.4 % Shares of LPCN opened at $5.08 on Friday. Lipocine has a 12 month low of $3.30 and […]

Maheshv patelLipocine incRenaissance technologiesGoldman sachs group incLipocine company profileBlackrock incMillennium managementFree reportGet free reportStreet corpGoldman sachs groupSachs groupLipocine dailyNasdaq lpcnInitiated coverageStocknews com